Representation for foreign manufacturers
Korea License Holder (KLH)
Foreign manufacturers must appoint a local authorized representative, also known as a Korea License Holder (KLH), who interacts with the regulatory authorities on the manufacturer’s behalf.
KLHs (Korea License Holders) must comply with some requirements, including established officially in the territory of South Korea,
- the employment of a certified Quality Manager,
- possession of an Import Business License,
- being an ICC - ICC-in-country caretaker
- responsibility for each importation and quality control “check,” etc.
Regulatory timelines and fees
All documentation that needs to be submitted to the authorities must be in Korean. Once a registration is completed, it remains valid indefinitely if no changes are made to the device or its intended use.
Approval timelines will vary depending on the risk class of the device.
Class I devices in Korea require electronic notification to the Medical Device Information & Technology Assistance Center (MDITAC), which is accredited by the MFDS for low-risk applications. Unlike the US FDA’s Class I listing system, manufacturers must provide detailed information about their device and technology but do not need to submit test reports or a KGMP certificate.
The MFDS may announce Class II devices in Korea approved and certified more than three times as 'Recognized Substantial Equivalent (SE) devices.'
Class III and IV devices require MFDS approval, and Class IV manufacturers must submit a technical file in Summary Technical Documentation (STED) format. The STED must be in Korean, though appendices like test reports and risk management files might not need translation. STED requirements are stricter than those for lower-risk devices.
All Class II-IV applications must include a comparison table to a substantially equivalent device registered with the MFDS. Devices without a South Korean market predicate need clinical data and will undergo Clinical Data Review (CDR)
Expected registration fees also depend on device risk classification and whether or not a registered predicate device or substantial equivalent (SE) device already exists in South Korea.